Author:
Blagodatskikh K. A.,Evdokimova M. A.,Agapkina Yu. V.,Nikitin A. G.,Brovkin A. N.,Pushkov A. A.,Blagodatskikh E. G.,Kudryashova O. Yu.,Osmolovskaya V. S.,Minushkina L. O.,Kochkina M. S.,Selezneva N. D.,Dankovtseva E. N.,Chumakova O. S.,Baklanova T. N.,Talyzin P. A.,Reznichenko N. E.,Donetskaya O. P.,Tereshchenko S. N.,Krasil’nikova E. S.,Dzhaiani N. A.,Akatova E. V.,Glezer M. G.,Galyavich A. S.,Zakirova V. B.,Koziolova N. A.,Timofeeva I. V.,Yagoda A. V.,Boeva O. I.,Katel’nitskaya L. I.,Khorolets E. V.,Shlyk S. V.,Volkova E. G.,Margaryan M. P.,Guz’ I. O.,Konstantinov V. O.,Timofeeva N. V.,Sidorenko B. A.,Zateishchikov D. A.,Nosikov V. V.
Subject
Structural Biology,Biophysics
Reference42 articles.
1. Nazarenko G.I., Kleimenova E.B., Gushchina N.N. 2009. Studies on genetic markers and traditional risk factors of ischemic heart disease. Ross. Med. Vesti. 14, 47–54.
2. Oganov R.G. Pogosova G.V., Koltunov I.E., Belova Yu.S., Vygodin V.A. 2008. RELIF—REgulyarnoe Lechenie I proFilaktika (regular treatment and prophylaxis)—a key to improving the situation with cardiovascular diseases in Russia: Results of a Russian muilticenter study, part 3. Kardiologiya. 48, 46–53.
3. Agapkina Y.V., Nikitin A.G., Brovkin A.N., et al. 2010. Polymorphic markers G(−455)A of gene FGB and C(−654)T of gene PROC and genetic predisposition to unfavorable outcomes in patients undergoing acute coronary syndrome. Mol. Biol. 44 (in press).
4. Paoletti R., Gotto A.M., Hajjar D. P. 2004. Inflammation in atherosclerosis and implications for therapy. Circulation. 109, III-20–III-26.
5. Titov V.N. 1999. Association of atherosclerosis and ion-flammation: Specificity of atherosclerosis as an inflammatory process. Ross. Kardiol. Zh. 5, 24–29.